Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) CEO Purchases $99,732.75 in Stock

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) CEO Timothy Goodnow acquired 17,225 shares of the stock in a transaction on Friday, March 13th. The stock was purchased at an average cost of $5.79 per share, with a total value of $99,732.75. Following the transaction, the chief executive officer directly owned 651,243 shares of the company’s stock, valued at $3,770,696.97. This represents a 2.72% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Senseonics Holdings, Inc. Common Stock Trading Up 11.4%

Shares of NASDAQ SENS traded up $0.64 during trading on Monday, reaching $6.28. 432,468 shares of the stock were exchanged, compared to its average volume of 508,324. The stock has a market cap of $262.48 million, a P/E ratio of -3.71 and a beta of 0.90. The company has a current ratio of 4.83, a quick ratio of 4.55 and a debt-to-equity ratio of 0.58. Senseonics Holdings, Inc. Common Stock has a twelve month low of $5.25 and a twelve month high of $15.74.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in SENS. First Light Asset Management LLC grew its holdings in Senseonics Holdings, Inc. Common Stock by 666.7% during the 2nd quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock worth $17,011,000 after acquiring an additional 31,050,619 shares in the last quarter. Hood River Capital Management LLC acquired a new position in Senseonics Holdings, Inc. Common Stock in the second quarter worth about $3,775,000. Sio Capital Management LLC bought a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at about $2,312,000. UBS Group AG raised its stake in Senseonics Holdings, Inc. Common Stock by 409.0% during the third quarter. UBS Group AG now owns 4,248,519 shares of the company’s stock valued at $1,852,000 after buying an additional 3,413,866 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Senseonics Holdings, Inc. Common Stock by 26.6% during the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock valued at $4,147,000 after buying an additional 1,828,302 shares in the last quarter. 12.36% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Weiss Ratings began coverage on Senseonics Holdings, Inc. Common Stock in a research note on Tuesday, February 17th. They set a “sell (d-)” rating for the company. Stifel Nicolaus set a $9.00 price target on Senseonics Holdings, Inc. Common Stock in a report on Tuesday, March 3rd. Finally, TD Cowen restated a “buy” rating on shares of Senseonics Holdings, Inc. Common Stock in a research note on Thursday, January 8th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.70.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.